Aptevo Therapeutics Inc.
APVONASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $2.03M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.37$30.06
- Volume (live)
- -
- Avg. volume (3M)
- 67.27K
Aptevo Therapeutics (APVO) Stock Price & Financial Analysis
Aptevo Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.60 - $1.73 |
|---|---|
| 52-Week High | $30.06 |
| 52-Week Low | $1.37 |
| Open | $1.73 |
| Volume (last close) | 30.92K |
| Average Volume (3M) | 67.27K |
| 50-Day MA | $2.32 |
|---|---|
| 200-Day MA | $4.82 |
| 1-Year Change | −94.02% |
| Market Cap | 2.03M |
|---|---|
| Shares Outstanding | 1.20M |
| Price to Book (P/B) | 0.34 |
| EV/EBITDA | 0.13 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Aptevo Therapeutics at a Glance
As of the Oct 16, 2026 close, Aptevo Therapeutics (APVO) has a market capitalization of $2.03M.
As of its latest reported balance sheet, it holds $9.80M in cash and securities against $4.21M of debt, a net cash position of $5.59M.
Aptevo Therapeutics does not currently pay a dividend.
The share price is down 94.0% over the past year. At $1.62 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $1.37 to $30.06, below its 200-day moving average of $4.82.
Frequently Asked Questions About Aptevo Therapeutics
What is the current stock price for APVO?
As of the Oct 16, 2026 close, APVO stock trades at $1.62. The 52-week range is $1.37–$30.06, with a day range of $1.60–$1.73.
What is the P/E ratio for APVO?
The P/E ratio (Price-to-Earnings) for APVO is shown in the Key Statistics section. This valuation metric helps compare Aptevo Therapeutics Inc. to industry peers.
Does APVO pay dividends?
Aptevo Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for APVO?
Analyst ratings and recommendations for APVO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of APVO?
As of the Oct 16, 2026 close, Aptevo Therapeutics's market capitalization is $1.9M, classifying it as a micro-cap company. Aptevo Therapeutics operates in the Healthcare sector within the Biotechnology industry.